Indian stock markets reopen after the Monday holiday (April 14) for Dr. Baba Saheb Ambedkar Jayanti. Here are the key stocks to watch:
Ircon International
- Secured a Letter of Acceptance worth ₹127 crore from North Western Railway.
Zydus Lifesciences
- Received final USFDA approval for Jaythari (Deflazacort) tablets, adding to its U.S. generics portfolio.
Ashoka Buildcon
- Declared L-1 bidder for a ₹569 crore project awarded by Central Railway.
Nureca
- Its manufacturing unit in Mohali secured US FDA registration, supporting export-led growth.
Aurobindo Pharma
- Received final ANDA approval from USFDA for Rivaroxaban Tablets, a key blood thinner.
Symphony
- Board approved an initiative to explore monetization of stakes in its subsidiaries.
Ahluwalia Contracts
- Bagged an order worth ₹396.5 crore from Godrej Properties.
Info Edge
- Announced May 7 as the record date for its upcoming stock split.
Cyient
- Won a green hydrogen project contract in Bodø, Norway, from GreenH and Luxcara.
Tata Power
- Signed a power purchase agreement with NTPC to develop a 200 MW renewable energy project.
Macrotech Developers (Lodha Group)
- Resolved brand dispute with House of Abhinandan Lodha, retaining exclusive rights to the ‘Lodha’ name.
Transrail Lighting
- Received domestic orders worth ₹1,085 crore in the rail and power sectors.
GMR Power & Urban Infra
- To divest stakes in subsidiaries to Synergy Group for ₹653 crore, enabling debt reduction of ₹4,400 crore.
Global Watch
- OPEC has trimmed global oil demand forecasts for 2025 and 2026, which may influence energy-related stocks.
